RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Chondroprogenitor directed differentiation protocol
We have developed a methodology for a chemically defined and effcient protocol which targets human embryonic stem cells towards a chondroprogenitor phenotype. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Muscle Wasting Disorders - Pipeline Review, Q1 2011
Jan 2011 - 42 pages - $500
Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011
Mar 2011 - 34 pages - $1,000
Muscle Wasting Disorders - Pipeline Review, Q3 2011
Jul 2011 - 112 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 84 pages - $500
Lyme Disease Global Clinical Trials Review, Q1, 2011
Feb 2011 - 26 pages - $1,000
Musculoskeletal Disorders Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Musculoskeletal Transplant Foundation - Medical Equipment - Deals and Alliances Profile
Mar 2011 - 16 pages - $250
GTx, Inc.: Company Profile and SWOT Analysis
Sep 2011 - 26 pages - $99
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us